Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-032295
Filing Date
2024-10-28
Accepted
2024-10-28 16:13:22
Documents
2
Period of Report
2024-10-28

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A inbp20241023_def14a.htm DEF 14A 508064
2 ibp_logo.jpg GRAPHIC 12671
  Complete submission text file 0001437749-24-032295.txt   526451
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31668 | Film No.: 241401046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)